Cargando…
A rare cutaneous phototoxic rash after vandetanib therapy in a patient with thyroid cancer: A case report
RATIONALE: Vandetanib is effective for treating symptomatic or progressive medullary thyroid cancer (MTC) in patients with unresectable locally advanced or metastatic disease, but its toxicity such as photosensitivity reactions should be considered. It is a rare adverse effect of this drug but might...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer Health
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709084/ https://www.ncbi.nlm.nih.gov/pubmed/31374006 http://dx.doi.org/10.1097/MD.0000000000016392 |